1. Home
  2. SOAR vs NXL Comparison

SOAR vs NXL Comparison

Compare SOAR & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Volato Group Inc.

SOAR

Volato Group Inc.

HOLD

Current Price

$0.17

Market Cap

11.3M

Sector

Finance

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.35

Market Cap

10.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOAR
NXL
Founded
2021
2010
Country
United States
United States
Employees
13
8
Industry
Blank Checks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
10.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SOAR
NXL
Price
$0.17
$0.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.7M
212.4K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.52
Revenue Next Year
N/A
$100.00
P/E Ratio
$0.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.31
52 Week High
$4.36
$2.00

Technical Indicators

Market Signals
Indicator
SOAR
NXL
Relative Strength Index (RSI) 44.43 38.49
Support Level $0.12 $0.35
Resistance Level $0.27 $0.46
Average True Range (ATR) 0.02 0.04
MACD -0.01 -0.01
Stochastic Oscillator 22.42 11.81

Price Performance

Historical Comparison
SOAR
NXL

About SOAR Volato Group Inc.

Volato Group Inc is an aviation technology company that connects travelers to private, on-demand flight access and develops proprietary software platforms for enterprise and operational applications. The company operates in a single operating and reportable segment, private aviation services. It operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: